New audio recordings from the case into alleged bribes and overpricing in the purchase of medications by the National Disability Agency (ANDIS) reveal links between the accused and the owners of Droguería Suizo Argentina, the brothers Emmanuel, Jonathan, and Eduardo Kovalivker. According to information accessed by the Argentine News Agency, the recordings broadcast on the program 'La Última Pregunta' include conversations between the accused Daniel María Garbellini, Pablo Atchabahian — the first person detained in the case — and Miguel Ángel Calvete, in which the Kovalivkers are mentioned directly. One of the most significant messages shows Garbellini writing to Atchabahian: 'It's important to have people with the right flag, and the flag of Switzerland.' This reference, according to the report, points to Droguería Suizo Argentina and its role in the network under judicial investigation. The report, which the Argentine News Agency accessed, detailed the existence of a WhatsApp group called 'Museo,' made up of businessmen who would have coordinated strategies to access state contracts at ANDIS. This group also included collaborators linked to the Kovalivker family, which reinforces the hypothesis of their direct involvement. On the judicial front, Federal Judge Sebastián Casanello had rejected a request for annulment presented by the Kovalivkers' defense, but the II Chamber of the Federal Court of Buenos Aires revoked that decision in early December, ordering an investigation into the origin and authenticity of the leaked audio recordings. According to the journalistic report, the billing of Suizo Argentina grew from $2,417 million in 2020 to $15,000 million in 2024. In addition, the connection between the Kovalivkers and Eduardo 'Lule' Menem, a political advisor, whose closeness to the family group could have influenced that remarkable economic growth, is mentioned.
New Recordings in ANDIS Corruption Case Link Accused to Pharmacy Chain Owners
New audio recordings in the ANDIS corruption case reveal links between accused individuals and the owners of Droguería Suizo Argentina. The pharmacy chain's revenue grew from $2.4 to $15 billion in four years. A court has revoked a decision to halt the investigation.